NCT06271369 Real-World HRU and Costs in DLBCL Pts With Tisa-cel and Axi-cel, a Medicare Study. Status COMPLETED Phase N/A
NCT06267560 Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD Status COMPLETED Phase PHASE3
NCT06254482 An Extension Study to Evaluate the Long-Term Safety and Efficacy of Votoplam in Participants With Huntington's Disease (HD) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06251986 A Cross-sectional Study to Assess the Effectiveness and Safety of Ofatumumab (Kesimpta®) in Patients With Relapsing Multiple Sclerosis in the Spanish Clinical Practice Status COMPLETED Phase N/A
NCT06251934 Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic Melanoma Status COMPLETED Phase N/A
NCT06249165 VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT06247995 A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. Status RECRUITING Phase PHASE1/PHASE2
NCT06240741 A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan Status COMPLETED Phase PHASE3
NCT06236724 Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. Status RECRUITING Phase PHASE2
NCT06236061 Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy Status COMPLETED Phase PHASE3
NCT06216249 Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) Status RECRUITING Phase PHASE2
NCT06215287 Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials Status COMPLETED Phase N/A
NCT06211153 Real-world Effectiveness of Asciminib and Treatment Patterns in Patients With Chronic Myeloid Leukemia With T315I Mutation - a Chart Review Study of Patients Treated in the Asciminib Managed Access Program (MAP) Status COMPLETED Phase N/A
NCT06184360 Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) Status COMPLETED Phase N/A
NCT06178770 Injection Intervals in Real-world Neovascular Age-related Macular Degeneration (nAMD) Patients Switching to Brolucizumab With at Least 12 Months of Follow-up Status COMPLETED Phase N/A
NCT06178393 Real-World Use of Novel Treatments in Patients With Spinal Muscular Atrophy (SMA): A Multi-Site Retrospective Chart Review of Pediatric SMA Patients Outside of the United States Status COMPLETED Phase N/A
NCT06172426 Incidence of Psoriatic Arthritis Among Psoriasis Patients Newly Initiated With Secukinumab in a US Claims Database and a UK Registry Status COMPLETED Phase N/A
NCT06161051 Treatment Patterns and Real-World Clinical Outcomes in Patients With Advanced NSCLC and MET Exon 14 Skipping Mutation in the United States Status COMPLETED Phase N/A